Non-Current Liabilities

Debt - Unamortized Discount (Premium) and Issuance Costs, Net

Amgen Debt - Unamortized Discount (Premium) and Issuance Costs, Net increased by 1.8% to $1.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.2%, from $1.35B to $1.33B. Over 5 years (FY 2020 to FY 2025), Debt - Unamortized Discount (Premium) and Issuance Costs, Net shows relatively stable performance with a 1.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026Apr 30, 2026

How to read this metric

Changes reflect the issuance of new debt or the amortization of existing discounts/premiums, impacting future interest expense.

Detailed definition

This represents the net adjustment to the face value of debt, accounting for the difference between the issuance price a...

Peer comparison

Standard accounting adjustment for any company with significant long-term debt instruments on its balance sheet.

Metric ID: debt_unamortized_discount_premium_issuance_costs

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.17B$1.22B$1.21B$1.25B$1.25B$1.25B$1.25B$1.43B$1.44B$1.42B$1.42B$1.40B$1.39B$1.37B$1.36B$1.35B$1.33B$1.32B$1.31B$1.33B
QoQ Change+4.0%-0.7%+3.3%-0.6%+0.6%-0.5%+15.1%+0.3%-1.0%-0.2%-1.1%-1.1%-1.2%-0.9%-1.1%-1.0%-1.1%-0.8%+1.8%
YoY Change+6.0%+2.5%+2.7%+14.4%+15.5%+13.7%+14.0%-2.1%-3.4%-3.5%-4.2%-4.2%-4.2%-4.1%-4.0%-1.2%
Range$1.17B$1.44B
CAGR+2.6%
Avg YoY Growth+2.4%
Median YoY Growth-1.6%

Debt - Unamortized Discount (Premium) and Issuance Costs, Net at Other Companies

Frequently Asked Questions

What is Amgen's debt - unamortized discount (premium) and issuance costs, net?
Amgen (AMGN) reported debt - unamortized discount (premium) and issuance costs, net of $1.33B in Q1 2026.
How has Amgen's debt - unamortized discount (premium) and issuance costs, net changed year-over-year?
Amgen's debt - unamortized discount (premium) and issuance costs, net decreased by 1.2% year-over-year, from $1.35B to $1.33B.
What is the long-term trend for Amgen's debt - unamortized discount (premium) and issuance costs, net?
Over 5 years (2020 to 2025), Amgen's debt - unamortized discount (premium) and issuance costs, net has grown at a 1.9% compound annual growth rate (CAGR), from $1.19B to $1.31B.
What does debt - unamortized discount (premium) and issuance costs, net mean?
The net adjustment to debt value representing issuance costs and the difference between issuance price and face value.